![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 05, 2021 12:04:21 PM
But a buyout is more practical, as some of the other Pharmas have more money, more expertise, and more Therapies/Vaccines ready to be utilized! Our IP's are great, and that drives eager beavers to our doors, but for us to make good moneywise, they must prove to do more than just express potential! I don't care how many Pharmas sign the dotted line to license our stuff out, but Medical practitioners must happily prescribe our Medicines, and regularly for us to be recognized as a Company of Geniuses?
In the field, Medical practitioners tend to go with Medicines of the past, even if they aren't perfect! Sorry, that's my opinion!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM